Providence Swedish Neuroscience Institute reaches milestone in reducing global burden of glioblastoma
The development of a proprietary immunotherapeutic puts Providence Swedish at the forefront of research and care for this aggressive, incurable type of brain tumor. Learn more.
Read Article